- Home
- APM vs HSDT Comparison
APM vs HSDT Comparison
Compare APM & HSDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APM
- HSDT
- Stock Information
- Founded
- APM 2010
- HSDT 2014
- Country
- APM United Kingdom
- HSDT United States
- Employees
- APM N/A
- HSDT N/A
- Industry
- APM Biotechnology: Pharmaceutical Preparations
- HSDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- APM Health Care
- HSDT Health Care
- Exchange
- APM Nasdaq
- HSDT Nasdaq
- Market Cap
- APM 4.1M
- HSDT 3.4M
- IPO Year
- APM 2018
- HSDT N/A
- Fundamental
- Price
- APM $1.15
- HSDT $0.75
- Analyst Decision
- APM
- HSDT Buy
- Analyst Count
- APM 0
- HSDT 2
- Target Price
- APM N/A
- HSDT $24.00
- AVG Volume (30 Days)
- APM 7.0M
- HSDT 8.1M
- Earning Date
- APM 12-20-2024
- HSDT 11-12-2024
- Dividend Yield
- APM N/A
- HSDT N/A
- EPS Growth
- APM N/A
- HSDT N/A
- EPS
- APM 0.00
- HSDT N/A
- Revenue
- APM N/A
- HSDT $502,000.00
- Revenue This Year
- APM $157,729.10
- HSDT N/A
- Revenue Next Year
- APM N/A
- HSDT $8.97
- P/E Ratio
- APM $345.64
- HSDT N/A
- Revenue Growth
- APM N/A
- HSDT N/A
- 52 Week Low
- APM $0.46
- HSDT $0.37
- 52 Week High
- APM $17.49
- HSDT $9.50
- Technical
- Relative Strength Index (RSI)
- APM 47.12
- HSDT 54.25
- Support Level
- APM $1.21
- HSDT $0.61
- Resistance Level
- APM $1.30
- HSDT $0.90
- Average True Range (ATR)
- APM 0.75
- HSDT 0.10
- MACD
- APM -0.06
- HSDT 0.00
- Stochastic Oscillator
- APM 4.58
- HSDT 48.76
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.
About HSDT Helius Medical Technologies Inc. (DE)
Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.